IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RANDON, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.811
NA - Nord America 1.013
AS - Asia 718
SA - Sud America 21
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 3.582
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 968
DE - Germania 895
CN - Cina 384
IT - Italia 267
SE - Svezia 182
GB - Regno Unito 177
IN - India 93
JP - Giappone 68
SG - Singapore 68
FR - Francia 60
IE - Irlanda 47
CA - Canada 44
DK - Danimarca 35
ES - Italia 35
HK - Hong Kong 25
NL - Olanda 22
BE - Belgio 15
ID - Indonesia 14
BR - Brasile 13
UA - Ucraina 13
AU - Australia 12
FI - Finlandia 12
TR - Turchia 12
KR - Corea 10
VN - Vietnam 10
CH - Svizzera 9
TW - Taiwan 9
PL - Polonia 8
GR - Grecia 6
CL - Cile 5
RU - Federazione Russa 5
AT - Austria 4
IR - Iran 4
UZ - Uzbekistan 4
AP - ???statistics.table.value.countryCode.AP??? 3
HU - Ungheria 3
MO - Macao, regione amministrativa speciale della Cina 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
AL - Albania 2
CO - Colombia 2
MY - Malesia 2
NO - Norvegia 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GL - Groenlandia 1
IL - Israele 1
MA - Marocco 1
PY - Paraguay 1
SA - Arabia Saudita 1
Totale 3.582
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 838
Chandler 222
Southend 146
Ashburn 89
Milan 72
Fairfield 58
Beijing 49
Redwood City 48
Wilmington 48
Dublin 47
Princeton 47
Ann Arbor 38
Dearborn 38
Singapore 36
Houston 33
Cambridge 30
Woodbridge 30
Toronto 29
Bengaluru 28
Shanghai 27
Des Moines 22
Seattle 21
Nanjing 20
Shenyang 19
Changsha 17
Phoenix 15
Brussels 14
Grafing 14
Central District 12
Guangzhou 12
Hangzhou 12
Helsinki 12
Jakarta 12
Jinan 12
New York 12
Hyderabad 11
Pune 11
Mumbai 10
Nanchang 9
Wuhan 9
Chengdu 8
Tianjin 8
Hefei 7
Rome 7
Seoul 7
Tokyo 7
Turin 7
Zhengzhou 7
Chicago 6
Falls Church 6
Genoa 6
Hong Kong 6
Lille 6
Paris 6
San Diego 6
São Paulo 6
Taizhou 6
Bologna 5
Fremont 5
Hebei 5
London 5
Ningbo 5
Orléans 5
Rho 5
Taipei 5
Upper Marlboro 5
Amsterdam 4
Athens 4
Berlin 4
Fuzhou 4
Haikou 4
Napoli 4
Patna 4
Pavia 4
Ranchi 4
Shizuoka 4
Andover 3
Bangkok 3
Baojishi 3
Bari 3
Bucharest 3
Bühl 3
Córdoba 3
Groningen 3
Hoorn 3
Hull 3
Merate 3
Málaga 3
Nantes 3
New Delhi 3
New Lambton 3
New Taipei City 3
Norwalk 3
Ottawa 3
Ourense 3
Padova 3
Palma 3
Rochester 3
Rotterdam 3
San Francisco 3
Totale 2.498
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer 597
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 305
The added value of baseline circulating tumor DNA profiling in patients with molecularly hyperselected, left-sided metastatic colorectal cancer 221
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 174
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 155
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden 149
The landscape of actionable gene fusions in colorectal cancer 144
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 137
Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies 135
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel : A Translational Analysis from the ITACA-S Trial. Oncologist 129
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer 122
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation 116
Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake 107
Atypical RAS Mutations in Metastatic Colorectal Cancer 103
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 103
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei 87
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial 86
KRAS G12C Metastatic Colorectal Cancer : Specific Features of a New Emerging Target Population 86
“Systemic strategy at the patient’s service”: A congress report on supportive care in oncology 85
MGMT Promoter Methylation as a Target In Metastatic Colorectal Cancer : Rapid Turnover and Use of Folates Alter its Study-Response 82
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer 72
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers 69
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study 67
The Italian instrument evaluating the nursing students clinical learning quality 66
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 64
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma 64
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy 63
Nursing students’ experience of the mental health setting as a clinical learning environment: Findings from a national study 61
Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience 51
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study 47
null 3
Totale 3.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020452 21 1 1 21 39 41 41 25 122 76 36 28
2020/2021531 31 42 39 30 54 59 29 40 71 33 36 67
2021/2022671 60 56 46 41 32 41 34 46 72 83 24 136
2022/2023714 72 102 81 71 57 120 21 60 52 13 46 19
2023/20241.323 26 36 46 49 86 42 221 167 84 158 202 206
Totale 3.750